NHS Choices Condition
Content supplied by NHS Choices
It's important to go to a reliable source for more information on psoriasis.
The National Institute for Health and Clinical Excellence (NICE) has produced healthcare guidelines on the treatment of psoriasis with biologics.
This guidance outlines NICE's main recommendations on when adalimumab (Humira), infliximab (Remicade), etanercept (Enbrel), efalizumab (Raptiva) and ustekinumab (Stelara) should be used to treat adults with plaque psoriasis in the NHS in England and Wales.
Download the NICE guidance on adalimumab
Download the NICE guidance on infliximab
Download the NICE guidance on etanercept and efalizumab
Download the NICE guidance on ustekinumabÂ
view information about Psoriasis on www.nhs.co.uk »Important Notice
The information provided on this website (including any NHS Choices medical information) is for use as information or for educational purposes only and is not a substitute for professional medical care by a qualified doctor or other qualified healthcare professional. We do not warrant that any information included within this site will meet your health or medical requirements. This Embarrassing Bodies site does not provide any medical or diagnostic services so you should always check with a health professional if you have any concerns about your health.
If you want to embed our videos in your site, read our embedding T&Cs here
Bookmark with